Monitoring Therapy with MEK Inhibitor U0126 in a Novel Wilms Tumor Model in Wt1 Knockout Igf2 Transgenic Mice Using (18)F-FDG PET with Dual-Contrast Enhanced CT and MRI: Early Metabolic Response Without Inhibition of Tumor Growth

PURPOSE: The understanding of the role of genetic alterations in Wilms tumor development could be greatly advanced using a genetically engineered mouse models that can replicate the development and progression of this disease in human patients and can be monitored using non-invasive structural and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores, Leo G., Yeh, Hsin-Hsien, Soghomonyan, Suren, Young, Daniel, Bankson, James, Hu, Qianghua, Alauddin, Mian, Huff, Vicki, Gelovani, Juri G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591528/
https://www.ncbi.nlm.nih.gov/pubmed/22875335
http://dx.doi.org/10.1007/s11307-012-0588-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591528/
https://www.ncbi.nlm.nih.gov/pubmed/22875335
http://dx.doi.org/10.1007/s11307-012-0588-5

Ejemplares similares